Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells

International Journal of Hematology
Shohei MizunoAkiyoshi Takami

Abstract

Amylase-producing myeloma exhibits refractoriness to chemotherapy and a dismal prognosis. In this study, we established a human myeloma cell line, 8226/AMY1, in which a lentivirally transfected AMY1 gene was stably expressed and explored its biological characteristics. 8226/AMY1 showed a survival advantage over mock control when treated with dexamethasone, bortezomib, and lenalidomide in vitro partly through inhibition of apoptosis induced by these reagents. In a xenograft murine model, 8226/AMY1 showed rapid tumor growth and reduced sensitivity to bortezomib compared with mock. A microarray gene expression analysis identified TCL1A, which functions as a coactivator of the cell survival kinase Akt, differentially up-regulated in 8226/AMY1. The expression of phosphorylated Akt was increased in the 8226/AMY1 cells following bortezomib treatment, but not in the mock cells. In addition, treatment with perifosine, an inhibitor of Akt phosphorylation, enhanced the anti-myeloma effect of bortezomib in the 8226/AMY1 cells. Our data suggest that amylase-producing myeloma reduced the sensitivity to bortezomib in vitro and in vivo, and the up-regulation of TCL1A may influence the drug susceptibility of 8226/AMY1 via the phosphorylation of...Continue Reading

References

Feb 1, 1991·Journal of Clinical Pathology·M HigashiyamaS Takai
Oct 25, 2001·Blood·J HsuA Lichtenstein
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Nicholas MitsiadesKenneth C Anderson
Mar 31, 2005·The Annals of Thoracic Surgery·Mitsuaki SakaiMasayuki Noguchi
Dec 3, 2005·Leukemia & Lymphoma·Massimiliano PinelliMaido Castiglioni
Feb 26, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Takanori Moriyama
Sep 30, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mohit AggarwalMiguel A Piris
Jan 1, 2009·BMJ Case Reports·Serena L HarbornePhilip T McAndrew
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul G RichardsonKenneth C Anderson
Mar 12, 2013·International Journal of Hematology·Reiko WatanabeMasahiro Kizaki
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R SosnoffStephen M J Hoffman
Jul 27, 2014·The Oncologist·Heinz LudwigAntonio Palumbo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis